Results 101 to 110 of about 28,003 (218)

Update on Current and Future Management for Diabetic Maculopathy. [PDF]

Ophthalmol Ther, 2022
Udaondo P, Parravano M, Vujosevic S, Zur D, Chakravarthy U.   +4 more
europepmc   +1 more source

Radiation Retinopathy: Case report and review [PDF]

, 2007
Background Ocular damage from radiation treatment is a well established phenomenon. Many factors are now known to influence the incidence of radiation retinopathy, including total dosage and daily fraction size. Patients who are diabetic, hypertensive or
Abha Gupta, Felipe Dhawahir-Scala, Amy Smith, Lorna Young, Steve Charles, RW Zamber, GC Brown, PHY Chee, GR Merriam, N Nakissa, DC Chacko, RC Chan, WM Wara, B Kumar, JS Sunness, AM Maguire, JL Kinyoun, PT Finger, PT Finger, PT Finger, CL Shields, FK Sutter, PG Hykin   +22 more
core   +2 more sources

EFFECT OF INTRAVITREAL TRIAMCINOLONE ACETONIDE IN REFRACTORY DIABETIC MACULAR EDEMA

Pakistan Armed Forces Medical Journal, 2021
Objective: To investigate the effects of intravitreal triamcinolone for refractory diabetic maculopathy after 03 unsuccessful intravitreal bevacizumab injections. Study Design: Prospective observational study.
Ume Sughra, Anwar Ahmed Gul, Kashif Habib, Zeeshan Khan, Ozeer Khan   +4 more
doaj  

Contribution of optical coherence tomography angiography OCT-A in diabetic maculopathy. [PDF]

Ann Med Surg (Lond), 2021
Mahjoub A, Cherni I, Khayrallah O, Ben Abdesslam N, Mahjoub A, Anas R, Ghorbel M, Mahjoub H, Knani L, Krifa F.   +9 more
europepmc   +1 more source

A Markov model of Diabetic Retinopathy Progression for the Economic Evaluation of a novel DR prognostic device, CHERE Working Paper 2007/14 [PDF]

The initial diagnosis of Diabetic Retinopathy (DR) is often in the advance stages of the condition, as patients are only promoted for an examination when sight has been affected.
Donald Martin, Julia Ting, Marion Haas
core  

Ocriplasmin in the treatment of vitreomacular traction in a patient with central retinal vein occlusion. a case report [PDF]

, 2018
Aim: To investigate the efficacy of intravitreal injection of ocriplasmin (JETREA®) in the treat-ment of vitreomacular traction (VMT). Materials and Methods: An 81-year-old man with VMT associated with central retinal vein occlusion in his left eye, was ...
Antonio Esposito, Raffaele, Mannino, Giuseppe, Rosati, Alessandra, Scuderi, Gianluca   +3 more
core   +2 more sources

Removal of Subfoveal Massive Hard Exudates through an Intentional Macular Hole in Patients with Diabetic Maculopathy: A Report of Three Cases. [PDF]

Case Rep Ophthalmol, 2022
Iwane Y, Imai H, Yamada H, Sotani Y, Oishi M, Nakamura M.   +5 more
europepmc   +1 more source

Analysis of microaneurysms and capillary density quantified by OCT-angiography and its relation to macular edema and macular ischemia in diabetic maculopathy. [PDF]

Eye (Lond), 2021
Khatri A, K C BK, Kharel M, K C A, Pradhan E.   +4 more
europepmc   +1 more source

Predicting 1, 2 and 3 year emergent referable diabetic retinopathy and maculopathy using deep learning

Communications Medicine
Background Predicting diabetic retinopathy (DR) progression could enable individualised screening with prompt referral for high-risk individuals for sight-saving treatment, whilst reducing screening burden for low-risk individuals.
Paul Nderitu, Joan M. Nunez do Rio, Laura Webster, Samantha Mann, M. Jorge Cardoso, Marc Modat, David Hopkins, Christos Bergeles, Timothy L. Jackson   +8 more
doaj   +1 more source

A Systematic Review and Meta-Analysis of Clinical Outcomes of Intravitreal Anti-VEGF Agent Treatment Immediately after Cataract Surgery for Patients with Diabetic Retinopathy

Journal of Ophthalmology, 2019
Aims. To examine possible benefits of intravitreal anti-vascular endothelial growth factor (VEGF) agent treatment immediately after cataract surgery for patients with diabetic retinopathy (DR). Methods.
Li-Quan Zhao, Jin-Wei Cheng
doaj   +1 more source